RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Avenue Therapeutics Stock

Avenue Therapeutics Market capitalization 2024

Avenue Therapeutics Market capitalization

354,412 USD

Ticker

ATXI

ISIN

US05360L2051

WKN

A2JH92

In 2024, Avenue Therapeutics's market cap stood at 354,412 USD, a -94.48% increase from the 6.42 M USD market cap in the previous year.

The Avenue Therapeutics Market capitalization history

YEARMarket Capitalization (undefined USD)
20239.46
202211.81
202157.21
2020142.05
201990.83
201841.98
201737.19
2016-
2015-

Avenue Therapeutics Aktienanalyse

What does Avenue Therapeutics do?

Avenue Therapeutics Inc is a biotechnology company specializing in the development of pain relief and anesthesia medications. The company was founded in 2015 and has since brought several products to the market. The core business of Avenue Therapeutics is the development of medications for pain and chronic pain. The company works with various compounds that selectively block pain receptors in the brain, including opioid receptors and cannabinoid receptors. The company currently has several products in the pipeline in different stages of clinical development. These include AV001, an anesthetic based on fentanyl used for pain relief in traumatic injuries and surgeries, and AV002, a pain medication based on tramadol used for acute and chronic pain. Another product being developed by the company is AV003, a synthetic cannabinoid compound that can be used for pain relief, as well as the treatment of anxiety disorders and seizures. In addition to their therapeutic effectiveness, all Avenue Therapeutics products are designed to be less addictive than traditional opioid medications. This goal is achieved through targeted dosing and special formulations. The business model of Avenue Therapeutics is based on the research, development, and marketing of pain medications and anesthetics. This includes production, clinical development, regulatory approval, and marketing in the healthcare market. Avenue Therapeutics has a wide range of customers, including hospitals, medical practices, and healthcare facilities, as well as patients suffering from pain and chronic pain. The products are offered in the North American market and can be purchased directly from the manufacturer or through sales by external distributors and retailers. An important goal of the company is to expand its product portfolio through the development of new and innovative pain medications. Therefore, the company continuously invests in research and development and collaboration with other companies and institutions to discover new technologies and compounds. However, the market for pain medications and anesthetics is highly competitive, and Avenue Therapeutics faces a range of challenges. These include stringent regulatory requirements, high costs for clinical trials, and a constant challenge to discover new technologies and compounds. Despite these challenges, Avenue Therapeutics has achieved impressive growth and a strong position in the market for pain medications and anesthetics in recent years. The company is in a good position to continue developing innovative medications in the future and provide its customers with a wide portfolio of high-quality pain relief drugs. Please indicate if these answers are enough or if you need further clarification. Avenue Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Avenue Therapeutics's Market Capitalization

Avenue Therapeutics's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Avenue Therapeutics's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Avenue Therapeutics's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Avenue Therapeutics’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Avenue Therapeutics stock

What is the current Avenue Therapeutics market capitalization?

The current market capitalization of Avenue Therapeutics is 354,412 USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Avenue Therapeutics.

How has the market capitalization of Avenue Therapeutics developed in recent years?

The market capitalization of Avenue Therapeutics has increased/decreased by -94.48% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Avenue Therapeutics?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Avenue Therapeutics?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Avenue Therapeutics have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Avenue Therapeutics pay?

Over the past 12 months, Avenue Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Avenue Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Avenue Therapeutics?

The current dividend yield of Avenue Therapeutics is .

When does Avenue Therapeutics pay dividends?

Avenue Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Avenue Therapeutics?

Avenue Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Avenue Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Avenue Therapeutics located?

Avenue Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Avenue Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Avenue Therapeutics from 9/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.

When did Avenue Therapeutics pay the last dividend?

The last dividend was paid out on 9/29/2024.

What was the dividend of Avenue Therapeutics in the year 2023?

In the year 2023, Avenue Therapeutics distributed 0 USD as dividends.

In which currency does Avenue Therapeutics pay out the dividend?

The dividends of Avenue Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Avenue Therapeutics

Our stock analysis for Avenue Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Avenue Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.